C. Risatti

发表

Gram-scale synthesis of (+)-spongistatin 1: development of an improved, scalable synthesis of the F-ring subunit, fragment union, and final elaboration.

Jeffrey B. Sperry, Amos B. Smith, Chris Sfouggatakis, 2008, Organic letters.

Preparation of the HIV Attachment Inhibitor BMS-663068. Part 2. Strategic Selections in the Transition from an Enabling Route to a Commercial Synthesis

Bin Zheng, Ke Chen, Martin D. Eastgate, 2017 .

Preparation of the HIV Attachment Inhibitor BMS-663068. Part 4. Synthesis of the 6-Azaindole Core

Richard L. Schild, Martin D. Eastgate, Christina A. Risatti, 2017 .

Synthesis of the 6-azaindole containing HIV-1 attachment inhibitor pro-drug, BMS-663068.

Martin D. Eastgate, Christina A. Risatti, Saravanababu Murugesan, 2014, The Journal of organic chemistry.

Development of a Scalable Route to a Dual NK-1/Serotonin Receptor Antagonist

D. Conlon, K. Natalie, Zhongping Shi, 2013 .

Overcoming Electronics with Strategy: Development of an Efficient Synthesis of the HIV Attachment Inhibitor Prodrug, BMS-663068

Martin D. Eastgate, Christina A. Risatti, K. Chen, 2015 .

Cyclopropane structural units from homoaldol adducts.

Richard E. Taylor, F. Engelhardt, M. Schmitt, 2003, Organic letters.

Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1.

Jeffrey B. Sperry, Clay S. Bennett, D. Gotchev, 2009, Tetrahedron.

Design, synthesis, and biological evaluation of diminutive forms of (+)-spongistatin 1: lessons learned.

Clay S. Bennett, Junke Liu, Amos B. Smith, 2011, Journal of the American Chemical Society.

Design, synthesis, and biological evaluation of EF- and ABEF- analogues of (+)-spongistatin 1.

Clay S. Bennett, Amos B. Smith, Karen Tendyke, 2010, Organic letters.

Engaging senior management to improve the safety culture of a chemical development organization thru the SPYDR (Safety as Part of Your Daily Routine) lab visit program

Sha Lou, Victor W. Rosso, Jonathan Marshall, 2019, Journal of Chemical Health & Safety.

The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.

M. Suckow, F. Castellino, R. Navari, 2004, Cancer letters.

The solution structure of (+)-spongistatin 1 in DMSO.

Christina Risatti, Onur Atasoylu, Amos B. Smith, 2010, Organic letters.

In vitro and in vivo anticancer activity of (+)-spongistatin 1.

Jeffrey B. Sperry, Qunli Xu, Junke Liu, 2011, Anticancer research.